Nojima Y, Minota S, Yamada A, Takaku F, Aotsuka S, Yokohari R
Third Department of Internal Medicine, Faculty of Medicine, Tokyo University, Japan.
Ann Rheum Dis. 1992 Sep;51(9):1053-5. doi: 10.1136/ard.51.9.1053.
Ninety one Japanese patients with systemic lupus erythematosus (SLE) were studied to determine the clinical significance of antibodies to ribosomal P protein (anti-P). Anti-P was detected by western blotting in 38 of 91 patients (42%). Clinical symptoms of SLE were compared between patients with and without anti-P. The occurrence of lupus psychosis was significantly higher in patients with anti-P than in those without anti-P (9/38 v 1/53). No significant association was found between anti-P and other symptoms of SLE. These data strongly support the suggestion proposed by previous workers that anti-P is a marker autoantibody for the development of lupus psychosis.
对91例日本系统性红斑狼疮(SLE)患者进行研究,以确定抗核糖体P蛋白抗体(抗-P)的临床意义。通过蛋白质印迹法在91例患者中的38例(42%)检测到抗-P。比较了有抗-P和无抗-P患者的SLE临床症状。有抗-P的患者中狼疮性精神病的发生率显著高于无抗-P的患者(9/38对1/53)。未发现抗-P与SLE的其他症状之间存在显著关联。这些数据有力地支持了先前研究者提出的抗-P是狼疮性精神病发生的标记自身抗体这一观点。